PsychoGenics Inc. Expands Its In Vivo Testing Capabilities with the Addition of Novel Neurogenesis Techniques in Partnership with KineMed, Inc.

TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics Inc. today announced the establishment of an alliance with KineMed, Inc. to provide specialized neurogenesis services to complement PsychoGenics’ in vivo testing capabilities.

Back to news